JP2022516090A5 - - Google Patents
Info
- Publication number
- JP2022516090A5 JP2022516090A5 JP2021537759A JP2021537759A JP2022516090A5 JP 2022516090 A5 JP2022516090 A5 JP 2022516090A5 JP 2021537759 A JP2021537759 A JP 2021537759A JP 2021537759 A JP2021537759 A JP 2021537759A JP 2022516090 A5 JP2022516090 A5 JP 2022516090A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025009594A JP2025066790A (ja) | 2018-12-28 | 2025-01-23 | 癌の治療において使用するためのｃｓｆ１ｒ阻害剤 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862786105P | 2018-12-28 | 2018-12-28 | |
| US62/786,105 | 2018-12-28 | ||
| US201962926341P | 2019-10-25 | 2019-10-25 | |
| US62/926,341 | 2019-10-25 | ||
| US201962933830P | 2019-11-11 | 2019-11-11 | |
| US62/933,830 | 2019-11-11 | ||
| PCT/US2019/068311 WO2020139828A1 (en) | 2018-12-28 | 2019-12-23 | Csf1r inhibitors for use in treating cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025009594A Division JP2025066790A (ja) | 2018-12-28 | 2025-01-23 | 癌の治療において使用するためのｃｓｆ１ｒ阻害剤 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022516090A JP2022516090A (ja) | 2022-02-24 |
| JPWO2020139828A5 JPWO2020139828A5 (https=) | 2024-03-12 |
| JP2022516090A5 true JP2022516090A5 (https=) | 2024-03-12 |
| JP7626702B2 JP7626702B2 (ja) | 2025-02-04 |
Family
ID=69191281
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537759A Active JP7626702B2 (ja) | 2018-12-28 | 2019-12-23 | 癌の治療において使用するためのｃｓｆ１ｒ阻害剤 |
| JP2025009594A Pending JP2025066790A (ja) | 2018-12-28 | 2025-01-23 | 癌の治療において使用するためのｃｓｆ１ｒ阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025009594A Pending JP2025066790A (ja) | 2018-12-28 | 2025-01-23 | 癌の治療において使用するためのｃｓｆ１ｒ阻害剤 |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US11103507B2 (https=) |
| EP (3) | EP4647767A3 (https=) |
| JP (2) | JP7626702B2 (https=) |
| KR (1) | KR20210119411A (https=) |
| CN (4) | CN118453608A (https=) |
| AU (3) | AU2019416117B2 (https=) |
| BR (1) | BR112021012812A2 (https=) |
| CA (1) | CA3124112A1 (https=) |
| DK (2) | DK3902547T3 (https=) |
| ES (2) | ES3049362T3 (https=) |
| FI (3) | FI3902547T3 (https=) |
| HR (2) | HRP20231478T1 (https=) |
| HU (2) | HUE073437T2 (https=) |
| IL (2) | IL284199B1 (https=) |
| LT (3) | LT4303583T (https=) |
| MX (2) | MX2021007927A (https=) |
| NO (1) | NO2026009I1 (https=) |
| PL (2) | PL3902547T3 (https=) |
| PT (2) | PT3902547T (https=) |
| RS (2) | RS67303B1 (https=) |
| SG (1) | SG11202105747XA (https=) |
| SI (2) | SI3902547T1 (https=) |
| SM (2) | SMT202500389T1 (https=) |
| TW (2) | TWI873113B (https=) |
| WO (1) | WO2020139828A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL276398B2 (en) | 2018-01-31 | 2026-03-01 | Deciphera Pharmaceuticals Llc | Combination therapy for mastocytosis |
| KR102708177B1 (ko) | 2018-01-31 | 2024-09-23 | 데시페라 파마슈티칼스, 엘엘씨. | 위장관 기질 종양의 치료를 위한 병용 요법 |
| SMT202500389T1 (it) * | 2018-12-28 | 2025-11-10 | Deciphera Pharmaceuticals Llc | Inibitori di csf1r per l'uso nel trattamento di tumori tenosinoviali a cellule giganti |
| EP3938363A1 (en) | 2019-03-11 | 2022-01-19 | Teva Pharmaceuticals International GmbH | Solid state forms of ripretinib |
| EP3966207B1 (en) | 2019-05-10 | 2023-11-01 | Deciphera Pharmaceuticals, LLC | Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof |
| MX2021013662A (es) | 2019-05-10 | 2022-03-11 | Deciphera Pharmaceuticals Llc | Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos. |
| IL325201A (en) | 2019-06-17 | 2026-02-01 | Deciphera Pharmaceuticals Llc | Aminopyrimidine amide autophagy inhibitors and methods of using them |
| LT4013412T (lt) | 2019-08-12 | 2026-03-25 | Deciphera Pharmaceuticals, Llc | Ripretinibas, skirtas virškinamojo trakto stromos navikų gydymui |
| PT4013412T (pt) | 2019-08-12 | 2026-03-18 | Deciphera Pharmaceuticals Llc | Ripretinib para o tratamento de tumores estromais gastrointestinais |
| CN115243681B (zh) | 2019-12-30 | 2024-08-16 | 德西费拉制药有限责任公司 | 1-(4-溴-5-(1-乙基-7-(甲氨基)-2-侧氧基-1,2-二氢-1,6-萘啶-3-基)-2-氟苯基)-3-苯基脲的组合物 |
| HRP20231699T1 (hr) | 2019-12-30 | 2024-05-10 | Deciphera Pharmaceuticals, Llc | Formulacije inhibitora amorfne kinaze i postupci njihove primjene |
| AU2021348477B2 (en) * | 2020-09-23 | 2023-12-21 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Csf1r kinase inhibitor and use thereof |
| MX2023005747A (es) | 2020-11-18 | 2023-07-28 | Deciphera Pharmaceuticals Llc | Inhibidores de gcn2 y perk quinasas y metodos de uso de los mismos. |
| CN113880812A (zh) * | 2021-11-17 | 2022-01-04 | 上海皓元生物医药科技有限公司 | 一种csf-ir抑制剂的制备方法 |
| KR20240113496A (ko) | 2021-12-03 | 2024-07-22 | 데시페라 파마슈티칼스, 엘엘씨. | Gcn2 및 perk 키나아제 억제제로서의 헤테로고리 화합물 |
| US12319655B2 (en) | 2021-12-09 | 2025-06-03 | Deciphera Pharmaceuticals, Llc | RAF kinase inhibitors and methods of use thereof |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
| EP4587059A2 (en) * | 2022-09-12 | 2025-07-23 | Ammax Bio, Inc | Treatment of tenosynovial giant cell tumor |
| EP4483866A1 (en) | 2023-06-28 | 2025-01-01 | Makrolife Biotech GmbH | Pharmaceutical compositions for the treatment or prevention of cancer |
| WO2025096349A1 (en) * | 2023-10-29 | 2025-05-08 | Deciphera Pharmaceuticals, Llc | Methods of treating tenosynovial giant cell tumors |
| CN117624132B (zh) * | 2023-11-28 | 2026-04-21 | 上海相辉医药科技有限公司 | 一种CSF-1R激酶抑制剂Vimseltinib(DCC-3014)的制备方法 |
| US20250206720A1 (en) | 2023-12-08 | 2025-06-26 | Deciphera Pharmaceuticals, Llc | Solid forms of an ulk inhibitor |
| WO2025122952A1 (en) * | 2023-12-08 | 2025-06-12 | Deciphera Pharmaceuticals, Llc | Formulations of vimseltinib |
| WO2025231106A1 (en) | 2024-05-01 | 2025-11-06 | Deciphera Pharmaceuticals, Llc | Csf-1r inhibitors and methods of use thereof |
| CN118593504B (zh) * | 2024-06-03 | 2025-03-18 | 北京大学第三医院（北京大学第三临床医学院） | 氘可来昔替尼或其盐在制备pvns药物方面的新用途 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5794047A (en) | 1980-12-01 | 1982-06-11 | Ricoh Co Ltd | Novel disazo compound and preparation of the same |
| KR100874791B1 (ko) | 2001-05-29 | 2008-12-18 | 바이엘 쉐링 파마 악티엔게젤샤프트 | Ｃｄｋ-억제 피리미딘, 그의 제조방법 및 약제로서의 용도 |
| EP2258366B1 (en) | 2001-06-22 | 2013-04-03 | Kirin Pharma Kabushiki Kaisha | Quinoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same |
| US7279576B2 (en) | 2002-12-31 | 2007-10-09 | Deciphera Pharmaceuticals, Llc | Anti-cancer medicaments |
| US7202257B2 (en) | 2003-12-24 | 2007-04-10 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
| US7144911B2 (en) | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
| WO2006071940A2 (en) | 2004-12-23 | 2006-07-06 | Deciphera Pharmaceuticals, Llc | Enzyme modulators and treatments |
| JP5345842B2 (ja) | 2005-06-23 | 2013-11-20 | アステックス・セラピューティクス・リミテッド | プロテインキナーゼモジュレーターとしてのピラゾール誘導体を含む医薬組み合わせ |
| PE20080359A1 (es) | 2006-04-19 | 2008-06-06 | Novartis Ag | Compuestos de benzoxazol y benzotiazol 6-0-sustituidos y metodos de inhibicion de la senalizacion de csf-1r |
| US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| US7897762B2 (en) | 2006-09-14 | 2011-03-01 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of proliferative diseases |
| US7790756B2 (en) | 2006-10-11 | 2010-09-07 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| US20080255155A1 (en) | 2006-10-18 | 2008-10-16 | Stephane Raeppel | Kinase inhibitors and uses thereof |
| EP2125781A2 (en) | 2006-12-20 | 2009-12-02 | Amgen Inc. | Substituted heterocycles and methods of use |
| KR20100014811A (ko) | 2007-04-20 | 2010-02-11 | 데시페라 파마슈티칼스, 엘엘씨. | 골수증식성 질환 및 기타 증식성 질환의 치료에 유용한 키나제 억제제 |
| ES2401550T3 (es) | 2008-02-28 | 2013-04-22 | Merck Patent Gmbh | Inhibidores de proteína cinasa y uso de los mismos |
| CN102256493A (zh) | 2008-10-29 | 2011-11-23 | 迪赛孚尔制药有限公司 | 表现出抗癌活性和抗增殖活性的环丙烷酰胺及其类似物 |
| BR112012027743A2 (pt) | 2010-04-29 | 2017-03-14 | Deciphera Pharmaceuticals Llc | ciclopropil dicarboxamidas e análogos exibindo atividades anticâncer e antiproliferativas |
| EP2563773A1 (en) | 2010-04-29 | 2013-03-06 | Deciphera Pharmaceuticals, LLC | Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites |
| BR112014012407A2 (pt) | 2011-11-22 | 2017-06-06 | Deciphera Pharmaceuticals Llc | amidas de piridona e análogos exibindo propriedades anti-câncer e anti-proliferativas |
| US9187474B2 (en) | 2012-03-07 | 2015-11-17 | Deciphera Pharmaceuticals, Llc | Raf inhibitor compounds |
| AR090151A1 (es) | 2012-03-07 | 2014-10-22 | Lilly Co Eli | Compuestos inhibidores de raf |
| US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| US9758258B2 (en) | 2012-11-29 | 2017-09-12 | Sirkorsky Aircraft Corporation | Rotary wing aircraft blade tracking |
| CA2903285C (en) | 2013-03-15 | 2021-05-11 | Deciphera Pharmaceuticals, Llc | 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities |
| RU2769607C2 (ru) | 2013-03-15 | 2022-04-04 | ДЕСИФЕРА ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | N-ацил-N'-(пиридин-2-ил) карбамиды и их аналоги, проявляющие противораковую и антипролиферативную активность |
| US9193719B2 (en) | 2013-03-15 | 2015-11-24 | Deciphera Pharmaceuticals, Llc | 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities |
| US9133183B2 (en) | 2013-03-15 | 2015-09-15 | Deciphera Pharmaceuticals, Llc | Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities |
| WO2014145004A1 (en) | 2013-03-15 | 2014-09-18 | Deciphera Pharmaceuticals, Llc | Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| US9309224B2 (en) | 2013-03-15 | 2016-04-12 | Deciphera Pharmaceuticals, Llc. | N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities |
| AR097584A1 (es) * | 2013-09-12 | 2016-03-23 | Hoffmann La Roche | Terapia de combinación de anticuerpos contra el csf-1r humano y anticuerpos contra el pd-l1 humano |
| US9457019B2 (en) | 2013-11-07 | 2016-10-04 | Deciphera Pharmaceuticals, Llc | Methods for inhibiting tie-2 kinase useful in the treatment of cancer |
| JP2020510673A (ja) | 2017-03-03 | 2020-04-09 | ヤンセン バイオテツク，インコーポレーテツド | がんの治療のための低分子ｃｓｆ−１ｒ阻害剤とｃｄ４０に特異的に結合するアゴニスト抗体とを含む併用療法 |
| EP3632906B1 (en) | 2017-05-24 | 2023-12-13 | Abbisko Therapeutics Co., Ltd. | Azaaryl derivative, preparation method therefor, and application thereof for use in pharmacy |
| EP3632907B1 (en) | 2017-05-24 | 2024-02-28 | Abbisko Therapeutics Co., Ltd. | N-(azaaryl)cyclolactam-1-carboxamide derivative, preparation method therefor, and use thereof |
| CA3065365C (en) | 2017-05-30 | 2025-09-16 | Deciphera Pharmaceuticals, Llc | USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDINE-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ITS ANALOGUES FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN THE PLATELET-DERIVED GROWTH FACTOR ALPHA RECEPTOR |
| CA3075892C (en) | 2017-09-14 | 2024-01-23 | Daiichi Sankyo Company, Limited | Heterocyclic compounds for the treatment and/or prevention of inflammatory diseases |
| IL276398B2 (en) | 2018-01-31 | 2026-03-01 | Deciphera Pharmaceuticals Llc | Combination therapy for mastocytosis |
| SMT202500389T1 (it) * | 2018-12-28 | 2025-11-10 | Deciphera Pharmaceuticals Llc | Inibitori di csf1r per l'uso nel trattamento di tumori tenosinoviali a cellule giganti |
| EP3966207B1 (en) | 2019-05-10 | 2023-11-01 | Deciphera Pharmaceuticals, LLC | Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof |
| MX2021013662A (es) | 2019-05-10 | 2022-03-11 | Deciphera Pharmaceuticals Llc | Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos. |
| TWI912522B (zh) | 2021-05-24 | 2026-01-21 | 大陸商上海和譽生物醫藥科技有限公司 | 一種結晶型csf-1r抑制劑酸式鹽及其製備方法和應用 |
| CN113880812A (zh) | 2021-11-17 | 2022-01-04 | 上海皓元生物医药科技有限公司 | 一种csf-ir抑制剂的制备方法 |
| CN116283919A (zh) | 2023-03-21 | 2023-06-23 | 上海皓元医药股份有限公司 | Vimseltinib的新晶型及其制备方法 |
-
2019
- 2019-12-23 SM SM20250389T patent/SMT202500389T1/it unknown
- 2019-12-23 RS RS20251011A patent/RS67303B1/sr unknown
- 2019-12-23 ES ES23195809T patent/ES3049362T3/es active Active
- 2019-12-23 MX MX2021007927A patent/MX2021007927A/es unknown
- 2019-12-23 HR HRP20231478TT patent/HRP20231478T1/hr unknown
- 2019-12-23 RS RS20231149A patent/RS64993B1/sr unknown
- 2019-12-23 CN CN202410608814.7A patent/CN118453608A/zh active Pending
- 2019-12-23 CN CN202410608820.2A patent/CN118453609A/zh active Pending
- 2019-12-23 CA CA3124112A patent/CA3124112A1/en active Pending
- 2019-12-23 HU HUE23195809A patent/HUE073437T2/hu unknown
- 2019-12-23 SG SG11202105747XA patent/SG11202105747XA/en unknown
- 2019-12-23 JP JP2021537759A patent/JP7626702B2/ja active Active
- 2019-12-23 HR HRP20251261TT patent/HRP20251261T1/hr unknown
- 2019-12-23 PL PL19842712.2T patent/PL3902547T3/pl unknown
- 2019-12-23 SI SI201930651T patent/SI3902547T1/sl unknown
- 2019-12-23 LT LTEP23195809.1T patent/LT4303583T/lt unknown
- 2019-12-23 CN CN202410608828.9A patent/CN118453610A/zh active Pending
- 2019-12-23 PT PT198427122T patent/PT3902547T/pt unknown
- 2019-12-23 DK DK19842712.2T patent/DK3902547T3/da active
- 2019-12-23 PT PT231958091T patent/PT4303583T/pt unknown
- 2019-12-23 LT LTEPPCT/US2019/068311T patent/LT3902547T/lt unknown
- 2019-12-23 FI FIEP19842712.2T patent/FI3902547T3/fi active
- 2019-12-23 SI SI201930977T patent/SI4303583T1/sl unknown
- 2019-12-23 CN CN201980092790.1A patent/CN113453684B/zh active Active
- 2019-12-23 HU HUE19842712A patent/HUE065492T2/hu unknown
- 2019-12-23 DK DK23195809.1T patent/DK4303583T3/da active
- 2019-12-23 KR KR1020217024011A patent/KR20210119411A/ko not_active Ceased
- 2019-12-23 WO PCT/US2019/068311 patent/WO2020139828A1/en not_active Ceased
- 2019-12-23 US US16/725,282 patent/US11103507B2/en active Active
- 2019-12-23 ES ES19842712T patent/ES2964489T3/es active Active
- 2019-12-23 BR BR112021012812A patent/BR112021012812A2/pt unknown
- 2019-12-23 EP EP25190979.2A patent/EP4647767A3/en active Pending
- 2019-12-23 AU AU2019416117A patent/AU2019416117B2/en active Active
- 2019-12-23 EP EP19842712.2A patent/EP3902547B1/en active Active
- 2019-12-23 SM SM20230468T patent/SMT202300468T1/it unknown
- 2019-12-23 PL PL23195809.1T patent/PL4303583T3/pl unknown
- 2019-12-23 FI FIEP23195809.1T patent/FI4303583T3/fi active
- 2019-12-23 EP EP23195809.1A patent/EP4303583B1/en active Active
- 2019-12-27 TW TW108148219A patent/TWI873113B/zh active
- 2019-12-27 TW TW114101930A patent/TW202541807A/zh unknown
-
2021
- 2021-06-20 IL IL284199A patent/IL284199B1/en unknown
- 2021-06-25 US US17/358,137 patent/US11679110B2/en active Active
- 2021-06-28 MX MX2024002838A patent/MX2024002838A/es unknown
-
2023
- 2023-04-28 US US18/140,942 patent/US12285430B2/en active Active
-
2024
- 2024-07-22 AU AU2024205010A patent/AU2024205010B2/en active Active
-
2025
- 2025-01-23 JP JP2025009594A patent/JP2025066790A/ja active Pending
- 2025-03-14 US US19/079,727 patent/US12485120B2/en active Active
- 2025-10-21 US US19/364,654 patent/US12582655B2/en active Active
- 2025-12-18 IL IL325448A patent/IL325448A/en unknown
-
2026
- 2026-01-30 AU AU2026200677A patent/AU2026200677A1/en active Pending
- 2026-03-03 NO NO2026009C patent/NO2026009I1/no unknown
- 2026-03-03 LT LTPA2026508C patent/LTPA2026508I1/lt unknown
- 2026-03-05 FI FIC20260007C patent/FIC20260007I1/fi unknown